tirzepatide cirrhosis Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? Pharmacological treatment of steatotic liver

Sep 2009;25(9):881-884

256,257 Gene expression profiling reveals altered lipid metabolism in nerves of patients with DPN and rodent models, suggesting that dysregulated lipid metabolism contributes to DPN

When to Seek Help: If nausea becomes severe or includes sharp stomach pain, contact a healthcare provider, as this may indicate a more serious condition

Methods Study Design and Procedures PIONEER REAL Sweden was a non-interventional, single-arm, phase 4, prospective, open-label study conducted across 28 centres in Sweden

Serious Pancreatic Risk: Pancreatitis Acute pancreatitis has been reported rarely in users using tirzepatide